A DOSE-RANGING, RANDOMIZED, PARALLEL, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECT OF TAK-954 ON GASTROINTESTINAL AND COLONIC TRANSIT IN PATIENTS WITH DIABETIC OR IDIOPATHIC GASTROPARESIS

Gastroenterology(2020)

引用 0|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要